• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来西亚首次急性缺血性卒中的直接医疗费用:一项回顾性队列研究。

Direct medical cost of first-ever acute ischemic stroke in malaysia: a retrospective cohort study.

作者信息

Mohammed Mustapha, Zainal Hadzliana, Ong Siew Chin, Tangiisuran Balamurugan, Aziz Fatimatuzzahra Abdul, Sha'aban Abubakar, Abubakar Usman, Sidek Norsima Nazifah, Looi Irene, Aziz Zariah A

机构信息

Biomedical Research Center, QU Health, Qatar University, Doha, Qatar.

School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia.

出版信息

Sci Rep. 2025 Jul 2;15(1):22571. doi: 10.1038/s41598-025-07026-1.

DOI:10.1038/s41598-025-07026-1
PMID:40596483
Abstract

Understanding the economic impact of first-ever stroke in a multiethnic population like Malaysia is essential for informed resource allocation. This study aimed to evaluate the direct medical costs associated with first-ever ischemic stroke in Malaysia. The study was a retrospective cohort study that estimated the inpatient direct medical costs of first-ever ischemic stroke in Malaysia. The study involved 122 adult patients managed at Hospital Sultanah Nur Zahirah, Terengganu (HSNZ), enrolled in the Malaysian National Stroke Registry (NSR) from 2009 to 2020. The mean ± standard deviation (SD) for the patients' age was 61.0 ± 10.9 years, the length of stay (LOS) was 4.5 ± 3.5 days, and the modified Rankin scale (mRS) score was 3.0 ± 1.1. Most patients experienced functional disability (poor functional status, mRS ≥ 3) and incurred an average (SD) treatment cost of MYR 1,970.7 ± 1,385.8, primarily attributed to hospital admissions and radiology expenses. The medical costs were significantly lower in patients with good functional status [mRS < 3 (p = 0.002)] and shorter LOS (p < 0.001), but higher in patients with the partial anterior circulation infarct (PACI) stroke subtype (p < 0.001). Additionally, patients with good functional status incurred significantly lower costs for admission and medications (p < 0.001). In conclusion, the inpatient direct medical cost of first-ever ischemic stroke in Malaysia is substantial and is influenced by stroke subtypes, length of stay, risk factors, and functional status. Strategies to reduce the length of stay, comorbidities, and functional status can potentially reduce the economic burden of the first-ever acute ischemic stroke. These findings are crucial for guiding the optimal allocation of resources for stroke care.

摘要

了解像马来西亚这样的多民族人群中首次中风的经济影响对于明智地分配资源至关重要。本研究旨在评估马来西亚首次缺血性中风的直接医疗费用。该研究是一项回顾性队列研究,估算了马来西亚首次缺血性中风的住院直接医疗费用。该研究纳入了2009年至2020年在登嘉楼苏丹娜努尔扎希拉医院(HSNZ)接受治疗并被纳入马来西亚国家中风登记册(NSR)的122名成年患者。患者的平均年龄±标准差(SD)为61.0±10.9岁,住院时间(LOS)为4.5±3.5天,改良Rankin量表(mRS)评分为3.0±1.1。大多数患者存在功能残疾(功能状态差,mRS≥3),平均(SD)治疗费用为1970.7±1385.8马来西亚林吉特,主要归因于住院和放射学费用。功能状态良好的患者[mRS<3(p=0.002)]和住院时间较短的患者(p<0.001)医疗费用显著较低,但部分前循环梗死(PACI)中风亚型的患者医疗费用较高(p<0.001)。此外,功能状态良好的患者住院和用药费用显著较低(p<0.001)。总之,马来西亚首次缺血性中风的住院直接医疗费用很高,且受中风亚型、住院时间、危险因素和功能状态的影响。缩短住院时间、减少合并症和改善功能状态的策略可能会减轻首次急性缺血性中风的经济负担。这些发现对于指导中风护理资源的优化分配至关重要。

相似文献

1
Direct medical cost of first-ever acute ischemic stroke in malaysia: a retrospective cohort study.马来西亚首次急性缺血性卒中的直接医疗费用:一项回顾性队列研究。
Sci Rep. 2025 Jul 2;15(1):22571. doi: 10.1038/s41598-025-07026-1.
2
Economic Burden of Major Depressive Disorder (MDD), Panic Anxiety, and Generalized Anxiety Disorder (GAD).重度抑郁症(MDD)、惊恐焦虑症和广泛性焦虑症(GAD)的经济负担。
J Ment Health Policy Econ. 2025 Jun 1;28(2):51-58.
3
Organised inpatient (stroke unit) care for stroke: network meta-analysis.中风的有组织住院(中风单元)护理:网状Meta分析
Cochrane Database Syst Rev. 2020 Apr 23;4(4):CD000197. doi: 10.1002/14651858.CD000197.pub4.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
Elective THA for Indications Other Than Osteoarthritis Is Associated With Increased Cost and Resource Use: A Medicare Database Study of 135,194 Claims.择期全髋关节置换术用于治疗非骨关节炎的适应证与更高的成本和资源利用相关:一项基于 Medicare 数据库的 135194 例患者的研究。
Clin Orthop Relat Res. 2024 Jul 1;482(7):1159-1170. doi: 10.1097/CORR.0000000000002922. Epub 2023 Nov 24.
6
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Sex-based differences in inflammatory predictors of outcomes in patients undergoing mechanical thrombectomy: an inverse probability weighting analysis.接受机械取栓治疗患者结局的炎症预测指标中的性别差异:逆概率加权分析
Ther Adv Neurol Disord. 2025 Jun 21;18:17562864251345719. doi: 10.1177/17562864251345719. eCollection 2025.
9
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
10
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.氯吡格雷与缓释双嘧达莫在闭塞性血管事件二级预防中的临床疗效与成本效益:一项系统评价与经济学评估
Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. doi: 10.3310/hta8380.

本文引用的文献

1
Prognostic Models of Mortality Following First-Ever Acute Ischemic Stroke: A Population-Based Retrospective Cohort Study.首次急性缺血性卒中后死亡率的预后模型:一项基于人群的回顾性队列研究。
Health Sci Rep. 2025 Feb 13;8(2):e70445. doi: 10.1002/hsr2.70445. eCollection 2025 Feb.
2
Epidemiology of First and Recurrent Ischemic Stroke in Sweden 2010-2019: A Riksstroke Study.2010-2019 年瑞典首次和复发性缺血性脑卒中的流行病学:一项 Riksstroke 研究。
Neuroepidemiology. 2022;56(6):433-442. doi: 10.1159/000527373. Epub 2022 Oct 12.
3
Validation of Stroke Risk Factors in Patients with Acute Ischemic Stroke, Transient Ischemic Attack, or Intracerebral Hemorrhage on Taiwan's National Health Insurance Claims Data.
基于台湾全民健康保险理赔数据对急性缺血性卒中、短暂性脑缺血发作或脑出血患者中风危险因素的验证
Clin Epidemiol. 2022 Mar 17;14:327-335. doi: 10.2147/CLEP.S353435. eCollection 2022.
4
The economic burden of stroke: a systematic review of cost of illness studies.卒中的经济负担:疾病成本研究的系统综述。
J Med Life. 2021 Sep-Oct;14(5):606-619. doi: 10.25122/jml-2021-0361.
5
Prevalence of and factors associated with stroke in hypertensive patients in Thailand from 2014 to 2018: A nationwide cross-sectional study.2014 年至 2018 年泰国高血压患者中风的患病率及相关因素:一项全国性横断面研究。
Sci Rep. 2021 Sep 2;11(1):17614. doi: 10.1038/s41598-021-96878-4.
6
Stroke risk factors, subtypes and outcome in elderly Thai patients.老年泰国患者的卒中危险因素、亚型和结局。
BMC Neurol. 2021 Aug 20;21(1):322. doi: 10.1186/s12883-021-02353-y.
7
Economic Burden of Stroke Disease: A Systematic Review.卒中疾病的经济负担:系统评价。
Int J Environ Res Public Health. 2021 Jul 15;18(14):7552. doi: 10.3390/ijerph18147552.
8
Trends in acute ischemic stroke treatments and mortality in the United States from 2012 to 2018.2012 年至 2018 年美国急性缺血性脑卒中治疗和死亡率的变化趋势。
Neurosurg Focus. 2021 Jul;51(1):E2. doi: 10.3171/2021.4.FOCUS21117.
9
Variations of risk factors for ischemic stroke and its subtypes in Chinese patients in Taiwan.台湾地区缺血性脑卒中及其亚型患者的危险因素变化。
Sci Rep. 2021 May 6;11(1):9700. doi: 10.1038/s41598-021-89228-x.
10
Acute Ischemic Stroke at High Altitudes in China: Early Onset and Severe Manifestations.中国高原地区的急性缺血性脑卒中:发病早且症状严重。
Cells. 2021 Apr 5;10(4):809. doi: 10.3390/cells10040809.